border=0
border=0
Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:   
border=0 border=0 Benefits: /
  • Your filings are automatically published to your site as they are filed.
  • Investors don't have to leave your site to see filings.


  • Product Description
  • Once a report has been filed with the SEC it will be available on the website.



  • SEC Filings Section 16 Filings Only
     
    NOVADEL PHARMA INC filed this 8-K on 08/12/2011.
    « Prev Page Outline Printer Friendly Entire FilingNext Page »
     

     

    NovaDel Pharma Inc.
    Condensed Statements of Operations

     (Unaudited)

     


       
    Three Months Ended June 30,
       
    Six Months Ended June 30,
     
       
    2011
       
    2010
       
    2011
       
    2010
     
    Revenue
                           
    Royalties
      $ 127,000     $     $ 127,000     $  
    Milestone fees
                          62,000  
    License fees
        65,000       66,000       130,000       133,000  
    Total revenue
        192,000       66,000       257,000       195,000  
                                     
    Operating expenses
                                   
    Research and development
        412,000       559,000       1,032,000       1,006,000  
    General and administrative
        703,000       813,000       1,385,000       1,787,000  
     Total operating expenses
        1,115,000       1,372,000       2,417,000       2,793,000  
                                     
    Loss from operations
        (923,000 )     (1,306,000 )     (2,160,000 )     (2,598,000 )
                                     
    Other income (expense):
                                   
    Change in derivative liability
        (2,427,000 )     181,000       3,684,000       181,000  
    Change in conversion feature liability
        (794,000 )           27,000        
    Interest expense
        (875,000       (1,000 )     (9,148,000 )     (1,000 )
    Total other income (expense)
        (4,096,000 )     180,000       (5,437,000 )     180,000  
                                     
    Net loss
       $ (5,019,000 )    $ (1,126,000 )    $ (7,597,000 )    $ (2,418,000 )
                                     
    Basic and diluted loss per common share
       $ (0.04 )    $ (0.01 )    $ (0.07 )     (0.03 )
                                     
    Weighted average common shares outstanding – basic and diluted
        129,080,346       97,918,458       115,961,695      $ 93,194,701  
                                     

     




    border=0
    Quote & Chart Package
    Basic Stock Chart
    Basic Stock Quote
    Embedded Quote / Chart
    Embedded Full Quote / Chart
    Interactive Chart
    Intraday Chart
    Pop Up Quote
    Scrolling Ticker

    You are viewing our Quote and Chart Demo using ticker symbol NVDL
    border=0

    T 800.650.1211     F 888.329.6696     E info@stockgroup.com   © 2004 Stockgroup Media Inc.    Disclaimer